A W Nienhuis

Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis.

D Orlic, S. Jane, A. Nienhuis, 1999, Blood.

"Silent" nucleotide substitution in a beta+-thalassemia globin gene activates splice site in coding sequence RNA.

T. Ley, A. Nienhuis, R. Humphries, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Beta O-39 thalassemia gene: a premature termination codon causes beta-mRNA deficiency without affecting cytoplasmic beta-mRNA stability.

T. Ley, A. Nienhuis, R. Humphries, 1984, Blood.

Cis-acting sequences that affect the expression of the human fetal gamma-globin genes.

G. Stamatoyannopoulos, S. Karlsson, A. Nienhuis, 1985, Progress in clinical and biological research.

Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.

J. Stamatoyannopoulos, A. Nienhuis, J A Stamatoyannopoulos, 1992, Annual review of medicine.

Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.

A. Schechter, A. Nienhuis, C. Noguchi, 1993, The New England journal of medicine.

Mechanism of DNase I hypersensitive site formation within the human globin locus control region.

A. Nienhuis, D. Bodine, C. Lowrey, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Hydroxyurea-induced HbF production in anemic primates: augmentation by erythropoietin, hematopoietic growth factors, and sodium butyrate.

A. Nienhuis, K. McDonagh, R. Donahue, 1992, Experimental hematology.

Treatment of Diamond‐Blackfan anaemia with haematopoietic growth factors, granulocyte‐macrophage colony stimulating factor and interleukin 3: sustained remissions following IL‐3

D A Smith, N. Young, A. Nienhuis, 1991, British journal of haematology.